@article{Haqqani_2024,

title = {Novel stop‑gain TSC2 gene mutation in an Indian child of tuberous sclerosis complex},

author = {Ruhi Haqqani and Sidra Rana and Nayeem Sadath Haneef and Omar Farooq and Vadlamudi Raghavendra Rao},

url = {https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11265763/pdf/IDOJ-15-657.pdf},

doi = {10.4103/idoj.idoj_469_23},

isbn = {2229-5178},

year  = {2024},

date = {2024-05-20},

urldate = {2024-05-20},

journal = {Indian Dermatology Online Journal},

volume = {15},

number = {pmid39050051},

issue = {4},

pages = {657-659},

keywords = {},

pubstate = {published},

tppubtype = {article}

}

@article{Sultan_2024,

title = {Sporotrichoid primary cutaneous nocardiosis: a rare case of isolated upper-limb involvement in a housewife},

author = {Juhi Fatima Sultan and Fatima Razvi and Nayeem Sadath Haneef and Sarwat Fatima},

url = {https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10969236/pdf/IDOJ-15-270.pdf},

doi = {10.4103/idoj.idoj_133_23},

isbn = {2229-5178},

year  = {2023},

date = {2023-10-05},

urldate = {2023-10-05},

journal = {Indian Dermatology Online Journal},

volume = {15},

number = {pmid38550836},

issue = {2},

pages = {270-273},

abstract = {Nocardiosis is a rare infection due to a ubiquitous, gram-positive, weakly acid-fast, filamentous, aerobic bacteria, that are usually responsible for opportunistic infection in immunocompromised patients. Less frequently, nocardiosis can affect immunocompetent patients, causing primary cutaneous infections. Here we present a case of a 45-year-old housewife with a 12-day history of red painful nodules arranged linearly on her right upper limb, without any apparent history of injuries or comorbidities, albeit with a hobby of gardening. The unusual yet characteristic presentation, microbiological findings, and excellent response to co-trimoxazole therapy were consistent with a diagnosis of sporotrichoid primary cutaneous nocardiosis. The uncommon lymphocutaneous presentation is often misdiagnosed. Therefore, keeping a high index of suspicion in such cases is important to improve the cure rate and prevent complications. },

keywords = {},

pubstate = {published},

tppubtype = {article}

}

@article{Kolli_2020,

title = {Cutaneous sarcoidosis with concomitant pulmonary tuberculosis},

author = {Deepti Kolli and Nayeem Sadath Haneef and Nikhat Fatima and B. Y. Praveen Kumar },

url = {https://www.ejmanager.com/mnstemps/154/154-1573410787.pdf?t=1698477846},

doi = {10.5455/jmas.73123},

issn = {2231-1696},

year  = {2020},

date = {2020-01-31},

urldate = {2020-01-01},

journal = {Journal of Medical and Allied Sciences},

volume = {10},

issue = {1},

pages = {33-36},

publisher = {ScopeMed},

abstract = {Sarcoidosis is a systemic disease of unknown etiology. It is characterized by the formation in all or several affected organs of epitheliod cell tubercles without caseation. Lupus pernio is a cutaneous manifestation of sarcoidosis. Tuberculosis is an important differential diagnosis for sarcoidosis and they closely resemble each other. We are reporting a rare case with classical features of lupus pernio who had concomitant pulmonary tuberculosis. Our patient presented with erythematous, indurated, plaques with scaling on the malar area of the face, cheeks and ear lobules which was consistent with lupus pernio both clinically and histologically. There was a history of weight loss (around 15%) and lethargy since 8 years, which coincided with onset of lesions. He developed high grade fever with sweating at night which lasted for more than 2 months and cough with expectoration. Chest examination revealed bilateral basal crepitations and Mantoux test was positive and broncho alveolar lavage showed acid fast bacilli. The patient was treated with anti-tubercular treatment followed by oral prednisolone over 3 months. Cutaneous lesions were treated with topical mild potency steroid along with intralesional triamcinolone. The overall response of the patient to treatment was satisfactory.},

keywords = {},

pubstate = {published},

tppubtype = {article}

}

@article{Razvi_2018,

title = {A clinico-aetiopathological study of palmoplantar keratoderma},

author = {Fatima Razvi and Nayeem Sadath Haneef and V. Sriteja and Chudi Kavya Reddy and Fatima Ummul Hasnath and Ramesh Bang},

url = {https://jemds.com/data_pdf/1_Nayeem,%20Iss%2013,%20Mar%2026,.pdf},

doi = {10.14260/jemds/2018/367},

issn = {2278-4748},

year  = {2018},

date = {2018-03-26},

urldate = {2018-03-26},

journal = {Journal of Evolution of Medical and Dental Sciences},

volume = {7},

issue = {13},

pages = {6808-6812},

abstract = {BACKGROUND: Palmoplantar keratodermas (PPKs) are a diverse entity of disorders that are characterised by abnormal thickening of the skin on the palms and soles. Over 50 types have been described and many of the inheritable types have been well documented in a review article by Itin and Fistarol. There is a considerable overlap and variation in clinical and histopathological feature of these conditions. Thus, a clinicopathological correlation is required for appropriate diagnosis. This would help in a better management of patients. Aims and Objectives- To study the various aetiological factors causing palmoplantar keratoderma (PPK), to study the

histopathological features of various types of palmoplantar keratoderma (PPK). MATERIALS AND METHODS:

Hundred (100) consecutive patients of palmoplantar keratoderma fulfilling the inclusion criteria, attending the outpatient Department of Dermatology, STD and leprosy, at the tertiary care centre of our medical college. After detailed history complete general, systemic and cutaneous examination was done with reference to lesions on the other parts of the body, any other dermatoses or systemic diseases. Skin biopsy was done in all the patients. Routine investigations like complete blood picture, complete urine examination, random blood sugar, serum creatinine and other tests like thyroid profile, VDRL, HIV 1 and 2 antibodies, potassium hydroxide mount of skin scrapings and PAS staining of biopsy section were done wherever necessary. Settings and Design- An observational study. RESULTS: Patient’s age ranged from 8 to 70 years (mean age being 31). Common age group was 11 - 20 years (24.00 %) followed by 21 - 30 years (22.00%), 31 - 40 years (20%), 41 - 50 years (14%), < 10 years (8%), 51 - 60 years (6%) and 61 - 70 years (6%), not seen between 71 - 80 years. Out of the total 100 patients studied, 44.00% were male and 56.00% were female patients. Male-to-female ratio was 0.78 showing female preponderance. Occurrence of PPK was seen among manual labourers (28.00%), students

(20.00%), housewives (16.00%) and agricultural workers (10.00%). Involvement of palms and soles was seen in 48.0% followed by soles 28.0% and palms in 24%. Clinically, 34% patients were diagnosed by psoriasis, 26% eczema, 10% HPPK, 8% pityriasis rubra pilaris, 8% with atopic dermatitis and 2% patients with drug-induced keratoderma and 10% patients with hereditary palmoplantar keratoderma. Histopathologically, out of 34 clinically diagnosed psoriasis 24 showed typical changes, while 18 out of 26 patients showed changes of eczema. All 6 clinically diagnosed patients showed typical changes of lichen planus. All 8 clinically diagnosed patients showed typical changes of Pityriasis rubra pilaris. CONCLUSION: The present study documented higher prevalence of palmoplantar keratoderma in the patients of age group 11 - 20 years with female preponderance. Psoriasis was more common among males and eczemas was more common in females.},

keywords = {},

pubstate = {published},

tppubtype = {article}

}

@article{Reddy_2018,

title = {Cutaneous changes in neonates in the first 72 hours of birth: an observational study},

author = {Harshita B. Reddy and Nayantara R. Gandra and Tina P. Katta},

url = {https://www.eurekaselect.com/article/81815},

doi = {10.2174/1573396313666170216120230},

issn = {1573-3963 },

year  = {2018},

date = {2018-01-01},

urldate = {2018-01-01},

journal = {Current Pediatric Reviews},

volume = {13},

issue = {2},

pages = {136-143},

publisher = {Bentham Science Publishers Ltd.},

abstract = {Background: Variation in neonatal skin changes and clinical presentation is a frequent occurrence. We studied the pattern of cutaneous manifestations in new-borns <72 hours of birth. Method: We included all live babies delivered in our hospital; Babies were categorised according to age, birth weight and gestational age. Neonates were examined within 24 hours of birth and daily for skin lesions for 72 hours. Skin lesions were categorised into physiological, transient eruptions, due to infections, congenital anomalies and miscellaneous. Results: Of 200 new-borns, 108 (54%) were females; 180 (90%) full term babies (37-41 weeks). Non-consanguinity was noted in parents of 175 (87.5%) babies. One hundred and thirty one (65%) babies were delivered normally by vaginal route, and 69 (34.5%) by Caesarean section. 176 (88.0%) were average birth weight babies. Mean±SD lesion burden/neonate was 3.925±1.2 (n=785 lesions, 1-8 lesions/neonate). Transient skin lesions were frequent (n=451 in 198 patients, Mean±SD 2.30±0.76) followed by physiological conditions (n=284, Mean±SD 1.44±0.82). Infectious, developmental, iatrogenic and miscellaneous lesions were less frequent (mean±SD lesions 0.015±0.12, 0.0115±0.32, 0.015±0.12, and 0.035±0.18, respectively). Statistically significant (p<0.001) relationship was noted between gestational age and number of lesions; more number of full term babies had lesions, while number of lesions (>6) were more in preterm babies. All lesions occurred within 24 hours of birth except erythema toxicum neonatorum (n=124) wherein 80 were seen on day 1, and 43 on day 2. Conclusion: We confirm the variation in cutaneous lesions and their time of onset in neonates. Transient and physiological changes are more frequent and disappeared spontaneously. Number of lesions/neonate was more in premature babies.},

key = {pmid28215177},

keywords = {},

pubstate = {published},

tppubtype = {article}

}

@article{Razvi_2017,

title = {Non-randomised control trial of glycolic acid 12% cream versus azelaic acid 10% cream in melasma},

author = {Fatima Razvi and Nayeem Sadath Haneef and Polishetty Sravanthi and Fatima Ummul Hasnath and Ramesh Bang},

url = {https://www.jemds.com/data_pdf/Nayeem,%20Dec%2018,.pdf},

doi = {10.14260/jemds/2017/1493},

issn = {2278-4748},

year  = {2017},

date = {2017-12-18},

urldate = {2017-12-18},

journal = {Journal of Evolution of Medical and Dental Sciences},

volume = {6},

issue = {94},

pages = {6891-6894},

abstract = {BACKGROUND: Melasma is most common acquired hypermelanosis which presents with asymmetrical hyperpigmentation usually involving the malar, mandibular or centrofacial area. It is seen in South East Asia especially in skin photo types 3 & 4. It is seen mainly in women during childbearing age and its onset may correlate with pregnancy or the use of oral contraceptive pills. The other commonly known factors in its pathogenesis include genetic influences, endocrine factors, use of cosmetics, certain drugs like anticonvulsants,

steroids and exposure to sunlight (UVA, UVB and visible light). Hydroquinone is being used for treatment of melasma since long time as it is efficacious, but it has adverse effects like contact dermatitis, exogenous ochronosis. Hence, we tried non-hydroquinone based topical medications which are safe, efficacious and are known to target melanocytes and various steps of melanogenesis. The aim of this study is to compare the efficacy of topical Glycolic acid 12% cream versus Azelaic acid 10% cream in melasma. MATERIALS AND METHODS: Settings and Design- Prospective non-randomised controlled trial of efficacy and safety of Glycolic acid 12% cream versus Azelaic acid 10% cream. 100 patients of melasma who completed all followups were included in this study for a period of 12 weeks and randomly assigned to one of the following groups: Group A - 12% Glycolic acid cream. Group B - 10% Azelaic acid cream. Statistical Analysis- Every 2 weeks and at the end of 12 weeks, the two treatment groups were compared for efficacy and adverse effects and the results were analysed with Chi-square test. Yates correction was applied wherever necessary. RESULTS: The response to Azelaic acid 10% cream was relatively higher than Glycolic acid 12% cream. Cut-offs were considered and these

differences were statistically significant (0.001 and 0.012). It was observed that higher proportion of patients with Glycolic acid 12% cream had adverse effects when compared to Azelaic acid 10% cream except for dryness. CONCLUSION: When the two topical medications were compared we found that Azelaic acid 10% cream was more tolerable and efficacious with maximum resolution than Glycolic acid 12% cream.},

keywords = {},

pubstate = {published},

tppubtype = {article}

}

@article{Koganti_2017,

title = {Report of two rare cases of Kindler‘s syndrome in siblings},

author = {Neha Chowdary Koganti and Nayeem Sadath Haneef and Fatima Razvi and B. Y. Praveen Kumar and Nikhat Fatima and Mohammed Altamash Zubair and Debasmita Chakraborty},

url = {https://jmas.in/fulltext/154-1488641936.pdf?1675745562},

doi = {10.5455/jmas.260417},

issn = {2231-1696},

year  = {2017},

date = {2017-07-31},

urldate = {2017-07-31},

journal = {Journal of Medical and Allied Sciences},

volume = {7},

issue = {2},

pages = {118-121},

abstract = {Kindler’s syndrome is a rare autosomal recessive disorder. It is characterized by trauma-induced blistering, photosensitivity, poikiloderma and mucosal inflammation. It occurs due to mutation on chromosome 20p.

This report describes two siblings with history of blistering and photosensitivity in childhood and later developed poikiloderma with histopathology of effected skin showing features of poikiloderma.},

keywords = {},

pubstate = {published},

tppubtype = {article}

}

@article{Zubair_2017,

title = {Report of three rare cases of Dowling Dego's disease},

author = {Mohammed Altamash Zubair and Nayeem Sadath Haneef and Fatima Razvi and B. Y. Praveen Kumar and Nikhat Fatima and Neha Chowdary Koganti},

url = {https://jmas.in/fulltext/154-1489068283.pdf?1675745759},

doi = {10.5455/jmas.260932},

issn = {2231-1696},

year  = {2017},

date = {2017-07-31},

urldate = {2017-07-31},

journal = {Journal of Medical and Allied Sciences},

volume = {7},

issue = {2},

pages = {122-125},

abstract = {Dowling Dego’s disease is a rare autosomal dominant condition. It is caused by loss of function mutations in keratin 5 gene (kRT5) situated in keratin gene cluster on 12q13. We are reporting three cases of Dowling Dego’s disease out of which two belong to same family. The clinical manifestations and histopathology were analyzed. All the three patients of which two were mother and son had symmetric, reticulate hyperpigmentation, pitted scars and acneiform eruption over face (predominantly perioral area, nasolabial folds), pinnae, upper trunk, thighs were seen. Palms, soles and scalp were spared. Buccal mucosa also showed reticulate hyperpigmentation. In addition the female patient had vulval reticulate hyperpigmentation and hydradenitis suppurativa affecting axillae, groins and inframammary folds. },

keywords = {},

pubstate = {published},

tppubtype = {article}

}

@article{Chakraborty_2017,

title = {A case report showing coexistence of two autoimmune diseses- psoriasis and vitiligo},

author = {Debasmita Chakraborty and Nayeem Sadath Haneef and Fatima Razvi and B. Y. Praveen Kumar and Nikhat Fatima and Neha Chowdary Koganti and Mohammed Altamash Zubair},

url = {https://jmas.in/fulltext/154-1488293321.pdf?1675746895},

doi = {10.5455/jmas.260021},

issn = {2231-1696},

year  = {2017},

date = {2017-07-31},

urldate = {2017-07-31},

journal = {Journal of Medical and Allied Sciences},

volume = {7},

issue = {2},

pages = {114-117},

abstract = {Psoriasis and vitiligo are autoimmune diseases. Occurrence of both these diseases in the same patient, especially at same sites is uncommon. Here, one such patient having both psoriasis and vitiligo lesions at the same site is being reported. An eight year old male patient presented with asymptomatic flat, white coloured, lesions over the left knee joint and left elbow joint since 3 years, followed by the appearance of multiple, asymptomatic red, scaly, elevated lesions over the pre-existing lesions since 10 days. There was no history of atopy, or drug intake/any applications or joint pains in this patient. There was family history of similar white coloured lesions and hypothyroidism. Cutaneous examination revealed well defined, polysized, depigmented

macules measuring around 5x3 cm with leukotrichia affecting the left knee joint and the left elbow joint. There were multiple, well defined, erythematous, plaques measuring around 2x2cm with silvery white scales over the extensor aspect of left elbow joint and left knee joint within the depigmented macules. Auspitz’s sign (peeling and pinpoint bleeding spots over the lesion on scrapping with a glass side) was positive. There was sparing of genitalia, palms, soles and scalp. Hair and nail was normal. A provisional diagnosis of vitiligo associated with psoriasis vulgaris was made, which was confirmed on histopathology. Both psoriasis and vitiligo lesions were treated accordingly. Occurrence of both vitiligo and psoriasis in the same patient and at same sites indicates similar etiopathogenesis. },

keywords = {},

pubstate = {published},

tppubtype = {article}

}

@article{Haneef_2017,

title = {A retrospective study of patient compliance to narrow band ultraviolet B phototherapy in vitiligo patients},

author = {Nayeem Sadath Haneef and B. Y. Praveen Kumar and Nikhat Fatima},

url = {https://jemds.com/data_pdf/Nayeem%202.pdf},

doi = {10.14260/Jemds/2017/366},

issn = {2278-4748},

year  = {2017},

date = {2017-03-13},

urldate = {2017-03-13},

journal = {Journal of Evolution of Medical and Dental Sciences},

volume = {6},

issue = {21},

pages = {1662-1666},

abstract = {BACKGROUND: Narrow band ultraviolet B (NBUVB) phototherapy is a well-established, effective and relatively safe treatment modality for treatment of vitiligo. An essential prerequisite for efficacy of NBUVB phototherapy is good compliance by patients. There is a paucity of literature on patient compliance to requisite number of sessions of NBUVB therapy in patients of vitiligo, where phototherapy is required for a prolonged duration.

MATERIALS AND METHODS: A 2-year retrospective analytical study was conducted to analyse patient compliance to NBUVB phototherapy in patients of vitiligo. All the patients were advised to visit the hospital for phototherapy thrice a week. Thus, in the initial 3 months (13 weeks), prescribed number of phototherapy sessions amounts to 39. Based on the actual number of phototherapy sessions completed by patients during this initial 3 months period, patient compliance to NBUVB therapy was graded as excellent (completion of > 75% of prescribed number of sessions), good (completion of >50-75 % of prescribed number of sessions), poor (completion of >25-50% of prescribed number of sessions) and very poor (completion of < 25 % of prescribed number of sessions). RESULTS: During the 2-year study period, 33 patients of vitiligo were prescribed narrow band UVB phototherapy, of which 11 patients dropped out after less than 8 sessions of phototherapy. Of the remaining 22 patients, only 5 patients (22.72%) had excellent compliance (completed > 75% of prescribed number of sessions), 3 patients (13.63%) had good compliance (>50-75% of prescribed number of sessions), 12 patients (54.54%) had poor compliance (>25-50% of prescribed number of sessions) and 2 patients (9.09%) had very poor compliance (<25% of prescribed number of sessions). Most common reasons for poor compliance

were difficulty in adjusting school/college timings (42.85%) and distance/transport problems (35.71%).

CONCLUSION: Poor patient compliance to narrow band UVB phototherapy, as observed in majority of patients in the present study, may be due to several reasons. Poor compliance may adversely impact the efficacy of this excellent therapeutic modality in patients of vitiligo. },

keywords = {},

pubstate = {published},

tppubtype = {article}

}

@article{Haneef_2017b,

title = {A retrospective study of duration of phase 1 of dexamethasone-cyclophosphamide pulse therapy in pemphigus patients},

author = {Nayeem Sadath Haneef and Fatima Razvi and B. Y. Praveen Kumar and Nikhat Fatima},

url = {https://jemds.com/data_pdf/Nayeem%201--.pdf},

doi = {10.14260/Jemds/2017/346},

issn = {2278-4748},

year  = {2017},

date = {2017-03-09},

urldate = {2017-03-09},

journal = {Journal of Evolution of Medical and Dental Sciences},

volume = {6},

issue = {20},

pages = {1575-1577},

abstract = {BACKGROUND: Dexamethasone-Cyclophosphamide Pulse (DCP) therapy, consisting of 4 phases is very effective, safe and inexpensive treatment modality for pemphigus patients. There are very few studies on duration of phase I in pemphigus, which affects the total duration of DCP therapy. 

MATERIALS AND METHODS: A 2-year retrospective analytical study was conducted to calculate duration of phase I of DCP therapy in 65 immuno-histopathologically confirmed patients of pemphigus.

RESULTS: Duration of phase I was less than 6 months in 31 patients (47.69%). It was 7 - 12 months in 27 patients (41.53%). Just 7 patients (10.76%) had to take phase I DCP for 12 - 18 months.

CONCLUSION: Duration of phase I of DCP was less than 12 months in majority of the patients (89.23%). This duration was less in 6 months in close to 50% of the patients.},

keywords = {},

pubstate = {published},

tppubtype = {article}

}

@article{Haneef_2016b,

title = {Pattern of patch test positivity in chronic urticaria patients in a tertiary care hospital in Telangana},

author = {Nayeem Sadath Haneef},

url = {https://www.jebmh.com/articles/pattern-of-patch-test-allergen-positivity-in-chronic-urticaria-patients-in-a-tertiary-care-hospital-in-telangana.pdf.pdf},

doi = {10.18410/jebmh/2016/524},

issn = {2349-2562},

year  = {2016},

date = {2016-06-13},

urldate = {2016-06-13},

journal = {Journal of Evidence Based Medicine and Healthcare},

volume = {3},

issue = {47},

pages = {2380-2384},

abstract = {CONTEXT: Patch test is the gold standard for detection of causative allergens in allergic contact dermatitis. Though chronic urticaria is a multifactorial condition, a sizeable number of such patients are thought to be due to various contact allergens. Hence, a hospital based prospective study of patch test positivity to various allergens was conducted in patients suffering from chronic urticaria. AIMS: To evaluate the pattern of allergen positivity in chronic urticaria patients by patch test using Indian Standard Series. SETTINGS & DESIGN: Prospective investigational study was conducted at Dermatology, Venereology and Leprosy department of a tertiary care hospital attached to a postgraduate training institute in Telangana state of India. METHODS & MATERIAL: Thirty chronic urticaria patients, above 18 years of age were evaluated with patch test of Indian standard series. Two of these patients had prior history of contact sensitivity to rubber and paraphenylenediamine. Patch test was done by application of allergens of Indian standard series over upper back. Patch test site was examined after 48 hours and after 72 hours. Patch test was considered positive if erythema, erythematous papules or vesicles were found at the site of application of corresponding allergen.

RESULTS: Patch test was positive in 4 out of 30 patients of chronic urticaria, fragrance, black rubber mix, paraphenylenediamine and parthenium being the allergens in 1 patient each. Patients with positive patch test to black rubber mix and paraphenylenediamine had prior history of contact allergy. CONCLUSION: Patch test is a simple, noninvasive, inexpensive and useful diagnostic test in a difficult to evaluate condition of chronic urticaria, irrespective of feasibility of avoidance of potential allergens. },

keywords = {},

pubstate = {published},

tppubtype = {article}

}

@article{Haneef_2016,

title = {A clinical observational study of orocutaneous manifestations in people living with HIV/AIDS},

author = {Nayeem Sadath Haneef},

url = {https://www.jemds.com/data_pdf/1_Nayeem.pdf},

doi = {10.14260/jemds/2016/479},

issn = {2278-4748},

year  = {2016},

date = {2016-05-02},

urldate = {2016-05-02},

journal = {Journal of Evolution of Medical and Dental Sciences},

volume = {5},

issue = {35},

pages = {2042-2048},

abstract = {CONTEXT: India has third highest prevalence of HIV/AIDS patients in the world. There were an estimated 2.31 million (1.8-2.9 million) people living with HIV/AIDS (PLHA) in India in 2007, whereas, slightly declining to 2.1 million in 2013. Early diagnosis of this infection is important not only for effective treatment of the affected patient but also for prevention of further transmission to others. Cutaneous manifestations can be an early pointer to this infection and hence play an important role in the control of HIV/AIDS. They are also useful for clinical staging (WHO staging) of these patients for therapeutic and prognostic purposes, especially in the absence of sophisticated laboratory facilities, as in many parts of India. The profile of cutaneous manifestations in HIV/AIDS patients varies according to their CD4 count. Some of these manifestations are also unique to certain geographic areas. AIMS: To study the local pattern of cutaneous and oral manifestations in people living with HIV/AIDS. SETTINGS AND DESIGN: A clinical, observational study was conducted among patients consulting Dermatology, Venereology and Leprosy Department of a Tertiary Care, Medical College Hospital in Telangana State, South India. METHODS AND MATERIAL: A total of 120 patients of HIV/AIDS, detected by ELISA or other tests, belonging to all age groups and sexes were included. RESULTS: Most common cutaneous manifestations observed were pruritic papular rash (20.8%), scabies (12.5%), folliculitis (11.7%), dermatophytosis (10.8%), xerosis (10.8%), seborrhoeic dermatitis (10%), drug rashes (9.2%), candidal vaginitis (5%), molluscum

contagiosum (4.2%), and herpes genitalis (3.3%). Oral candidiasis was the commonest oral mucosal manifestation (37.5%). CONCLUSION: Most of the cutaneous and oral manifestations found in PLHA were concurrent with previous studies, but high incidence of pruritic papular rash is an interesting finding of this study.},

keywords = {},

pubstate = {published},

tppubtype = {article}

}

@article{Razvi_2015,

title = {Primary varicella infection associated with Steven-Johnson syndrome},

author = {Fatima Razvi and Mohammed Zoheb and Nayeem Sadath Haneef and Neha Chowdary Koganti},

url = {https://jmas.in/fulltext/154-1451056519.pdf?1675747859},

issn = {2231-1696},

year  = {2015},

date = {2015-08-31},

urldate = {2015-08-31},

journal = {Journal of Medical and Allied Sciences},

volume = {5},

issue = {2},

pages = {38-40},

abstract = {Steven-Johnson Syndrome (Erythema Multiforme Major) is a severe occasionally fatal variant of Erythema Multiforme which is abrupt in onset accompanied by fever, malaise, headache and erosions of conjunctiva, mouth and genitilia with skin lesions in the form of erythematous macules, papules and target lesions involving less than 10% of body surface area. Varicella is caused by varicella zoster virus. It is a primary infection with a viraemic stage after which the virus persists in the sensory nerve ganglia cells, reactivation of which in the later life results in herpes zoster.Varicella is transmitted by droplet infection. Patients are usually infectious 2 days prior to 5 days after the onset of rash. Varicella confers lasting immunity and second attacks are uncommon in immunocompetent individuals. Immunoglobulin(Ig), IgG, IgM, IgA antibodies appear in about 1 week after the

onset and the peak levels occur during the second and third week thereafter the titred gradually all. Immunoglobulins have incomplete protective effect, CMI is more important against the infection and if the primary infection occurs when CMI is impaired as in organ transplant patients it maybe fatal.We, report a rare association of primary varicella with Steven Johnsons Syndrome successfully treated with a combination of systemic steroids and Acyclovir. },

keywords = {},

pubstate = {published},

tppubtype = {article}

}

@article{Razvi_2015b,

title = {Generalized pustular psoriasis of pregnancy},

author = {Fatima Razvi and Nayeem Sadath Haneef and Sri Teja and Ramesh Bang and Fatima Ummul Hasnath},

url = {https://jmas.in/fulltext/154-1451059982.pdf?1675747796},

issn = {2231-1696},

year  = {2015},

date = {2015-08-31},

urldate = {2015-08-31},

journal = {Journal of Medical and Allied Sciences},

volume = {5},

issue = {2},

pages = {51-53},

abstract = {eneralized pustular psoriasis also called as Impetigo Herpetiformis is a rare eruption occurring in pregnancy characterized by generalized symmetrical grouped pustular lesions associated with constitutional symptoms.

It was first described by Von Hebra. It results in placental insufficiency leading to fetal anomalies, still births and maternal morbidity. Onset of diseases is usually in the last trimester of pregnancy but we are reporting a case which occurred at 9 weeks gestation.},

keywords = {},

pubstate = {published},

tppubtype = {article}

}

@article{Razvi_2015c,

title = {Cryoglobulin induced skin ulceration},

author = {Fatima Razvi},

url = {https://jmas.in/fulltext/154-1451055142.pdf?1698478102},

issn = {2231-1696},

year  = {2015},

date = {2015-01-31},

urldate = {2015-01-31},

journal = {Journal of Medical and Allied Sciences},

volume = {5},

issue = {1},

pages = {21-23},

abstract = {Lupus Erythematosus (LE) is a multi-organ auto-immune disease which results from complex interaction of genetic and environmental factors. The clinical spectrum ranges from minor cutaneous lesions to life threatening multi-organ dysfunction. The skin manifestations are variable and common and range from LE specific to LE non-specific cutaneous disease. Vasculitis is one of the most common non-specific skin lesion of Systemic lupus erythematosus (SLE) and appears as purpuric lesions, infarcts along lateral nail folds, peripheral gangrene, sub-cutaneous nodules and ulcers. Mixed cryoglobulinaemia (type II) is associated with connective

tissue disorders including SLE. Skin manifestations are seen in 60-100% patients and are more common in females. The most common manifestation is palpable purpura of lower extremities seen in 30-100% which often is triggered in winter or on cold exposure. Skin infarction, hemorrhagic crusts and ulcers are seen in

25% of patients. Wide spread necrotic ulcers are seen in 10-25% of patients which are often exacerbated by cold. },

keywords = {},

pubstate = {published},

tppubtype = {article}

}

@article{Chacham_2014,

title = {Epidermolysis bullosa in a small for gestational age preterm male neonate with two affected siblings: a case report},

author = {Swathi Chacham and Jakkampudi Nagasravani and Uppin Narayan Reddy and J. Narsing Rao and S. Pratap Rao and A. S. Kumar},

url = {https://www.ijcasereportsandimages.com/archive/2014/010-2014-ijcri/CR-10433-10-2014-chacham/ijcri-1043310201433-chacham.pdf},

doi = {10.5348/ijcri-2014122-CR-10433},

issn = {0976-3198},

year  = {2014},

date = {2014-10-01},

urldate = {2014-10-01},

journal = {International Journal of Case Reports and Images},

volume = {5},

issue = {10},

pages = {691-694},

abstract = {Introduction: Epidermolysis bullosa is a rare group of hereditary disorders, which are characterized by blistering of the skin and mucosa due to little or no apparent trauma. The severity can range from mild, localized skin blisters to generalized, systemic life-threatening disease and the treatment is mainly supportive. Dystrophic type of epidermolysis bullosa is one of the rarer forms. Skin fragility often leads to secondary skin infections and in turn generalized infection which can be lethal. Hence, the major challenge encountered in the care of a neonate with epidermolysis bullosa is optimum skin care and expert nursing care. A preterm, small for gestational age (SGA) neonate, has immature skin physiologically, which is a portal for systemic infection when compared to a term appropriate for gestational age neonate. The presence of blistering lesions in a preterm, SGA neonate further challenges the management. Case Report: We report a preterm, low birth weight (small for gestational age) male neonate, who had extensive bullous lesions and dystrophic nails in the first week of life. These lesions healed by scarring leading to stiffness of underlying joints and were complicated by secondary infection. There was history of consanguinity and previous two siblings also had similar lesions with contractures. Conclusion: A preterm male small for gestational age neonate born of consanguineous marriage, with the history of cutaneous bullous lesions in two siblings, presented with extensive bullous lesions and dystrophic nails, suggestive of dystrophic epidermolysis bullosa. },

keywords = {},

pubstate = {published},

tppubtype = {article}

}

@article{Razvi_2013,

title = {Clinical and histo pathological study of primary cutaneous macular amyloidosis},

author = {Fatima Razvi and A. S. Kumar},

url = {https://jmas.in/fulltext/154-1450011426.pdf?1676002667},

issn = {2231-1696},

year  = {2013},

date = {2013-02-28},

urldate = {2013-02-28},

journal = {Journal of Medical and Allied Sciences},

volume = {3},

issue = {1},

pages = {22-25},

abstract = {Primary cutaneous amyloidosis often presents with pigmentary dystonias of the skin in the form of asymptomatic reticulate hyperpigmentation or pruritic lichenoid papular lesions. The aim of this study was to evaluate the incidence of primary cutaneous macular amyloidosis and also to find out the possible etiological agents, to correlate their clinical disease with histopathological positivity for amyloid deposition, and to find out the percentage of positive cases by special stains. A total of 24 patients attending dermatology

out-patient clinic of Princess Esra Hospital, Hyderabad over a period of 1 year presenting with hyperpigmented skin lesions and clinically diagnosed as macular amyloidosis were taken up for this study. },

keywords = {},

pubstate = {published},

tppubtype = {article}

}